NARCAN TWINDOSE

Serial Number 88863745
606

Registration Progress

Application Filed
Apr 8, 2020
Under Examination
Sep 29, 2020
Approved for Publication
Aug 4, 2020
Published for Opposition
Aug 4, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NARCAN TWINDOSE
Previous Owner: EMERGENT OPERATIONS IRELAND LIMITED
Classes: 005

Trademark Image

NARCAN TWINDOSE

Basic Information

Serial Number
88863745
Filing Date
April 8, 2020
Published for Opposition
August 4, 2020
Abandonment Date
October 30, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 30, 2023
Classes
005

Rights Holder

EMERGENT OPERATIONS IRELAND LIMITED

77
Address
6 EARLSFORT TERRACE
6TH FLOOR
DUBLIN 2
IE

Ownership History

Adapt Pharma Operations Limited

Original Applicant
16
Dublin 2 IE

Adapt Pharma Operations Limited

Owner at Publication
16
Dublin 2 IE

EMERGENT OPERATIONS IRELAND LIMITED

New Owner After Publication #1
77
DUBLIN IE

Legal Representation

Attorney
Virginia Wolk Marino

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

32 events
Date Code Type Description Documents
Oct 30, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 30, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 21, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 9, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Mar 21, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Mar 9, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 14, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 14, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 11, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 9, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 9, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 9, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 20, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 20, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Mar 6, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 4, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 4, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 4, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 4, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 15, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 26, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 26, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 15, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 11, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations

Additional Information

Pseudo Mark
NARCAN TWIN DOSE

Classification

International Classes
005